SecSonar.com

bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

bioAffinity Technologies, Inc. (BIAF) is a Medical - Diagnostics & Research company based in US with a market capitalization of $7.7M. Revenue declined 34.2% year-over-year and free cash flow was negative at -$9.4M. This page tracks BIAF's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 57 employees · IPO Sep 1, 2022

Valuation

Valuation & price

$1.88 · as of May 17, 2026 · -82.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.05

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.95$5.88$0.81Jul 25Dec 25Jul 26Jul 7, 25$8.79Jul 9, 25$10.20Jul 11, 25$9.20Jul 15, 25$8.79Jul 17, 25$9.96Jul 21, 25$10.95Jul 23, 25$10.43Jul 25, 25$10.02Jul 29, 25$9.71Jul 31, 25$9.51Aug 4, 25$9.12Aug 6, 25$8.69Aug 11, 25$8.37Aug 13, 25$8.40Aug 15, 25$6.99Aug 19, 25$8.02Aug 21, 25$7.47Aug 25, 25$7.48Aug 27, 25$7.44Aug 29, 25$7.26Sep 3, 25$7.41Sep 5, 25$7.17Sep 9, 25$7.44Sep 11, 25$7.65Sep 16, 25$7.83Sep 18, 25$5.07Sep 22, 25$5.17Sep 24, 25$4.29Sep 26, 25$5.29Sep 30, 25$2.96Oct 2, 25$2.78Oct 6, 25$2.56Oct 8, 25$3.05Oct 10, 25$2.72Oct 14, 25$2.88Oct 16, 25$3.41Oct 21, 25$2.83Oct 23, 25$2.64Oct 27, 25$2.59Oct 29, 25$2.48Oct 31, 25$2.45Nov 4, 25$2.09Nov 6, 25$2.05Nov 10, 25$2.09Nov 12, 25$2.15Nov 14, 25$1.84Nov 18, 25$1.47Nov 20, 25$1.38Nov 25, 25$1.43Nov 28, 25$1.50Dec 2, 25$1.43Dec 4, 25$1.72Dec 8, 25$1.65Dec 10, 25$1.69Dec 12, 25$1.51Dec 16, 25$1.38Dec 18, 25$1.22Dec 22, 25$1.27Dec 24, 25$1.23Dec 29, 25$1.17Jan 2, 26$1.22Jan 6, 26$1.29Jan 8, 26$1.29Jan 12, 26$1.27Jan 14, 26$1.26Jan 16, 26$1.37Jan 21, 26$1.31Jan 23, 26$1.35Jan 27, 26$1.32Jan 29, 26$1.17Feb 2, 26$1.27Feb 4, 26$0.86Feb 9, 26$0.90Feb 11, 26$0.99Feb 13, 26$1.04Feb 18, 26$1.15Feb 20, 26$1.08Feb 24, 26$1.11Feb 26, 26$1.04Mar 2, 26$1.06Mar 4, 26$1.03Mar 6, 26$1.04Mar 10, 26$1.19Mar 12, 26$1.07Mar 17, 26$2.74Mar 19, 26$2.97Mar 23, 26$4.73Mar 25, 26$3.97Mar 27, 26$4.00Mar 31, 26$3.83Apr 2, 26$3.92Apr 7, 26$4.09Apr 9, 26$3.32Apr 13, 26$3.18Apr 15, 26$2.93Apr 17, 26$2.86Apr 22, 26$2.51Apr 24, 26$2.23Apr 28, 26$2.66Apr 30, 26$2.49May 4, 26$2.18May 6, 26$1.98May 8, 26$2.03May 12, 26$1.88May 14, 26$1.99May 18, 26$1.69May 20, 26$1.66May 22, 26$1.56May 28, 26$1.65Jun 1, 26$1.75Jun 3, 26$1.69Jun 5, 26$1.73Jun 9, 26$1.51Jun 11, 26$1.63Jun 15, 26$1.37Jun 17, 26$0.83Jun 22, 26$0.81Jun 24, 26$0.85Jun 26, 26$0.83Jul 2, 26$0.83
$0.7552-week range$10.95
Loading valuation history…

Fundamentals

Key fundamentals

$7.7M

Market cap

-34.2%

Revenue growth (YoY)

23.2%

Gross margin

-$9.4M

Free cash flow (USD)

-$5.3M

Net debt

Net cash position

325.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$4.8KFY 2023$2.5MFY 2024$9.4MFY 2025$6.2M
$0$6.2M

Free cash flow by year

2019 → 2025

FY 2019$-2.5MFY 2020$-2.2MFY 2021$-2.0MFY 2022$-4.3MFY 2023$-6.1MFY 2024$-7.3MFY 2025$-9.4M
-$2.5M-$9.4M

Gross margin by year

2022 → 2025

FY 202290.3%FY 202331.3%FY 202436.1%FY 202523.2%
90.3%23.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCompany Newsletter ReleasedJun 30, 2026Filing
  • 8-K eventSecurities Purchase AgreementJun 18, 2026Filing
  • 8-K eventWebinar AnnouncementJun 16, 2026Filing
  • 8-K eventWebinar AnnouncementJun 2, 2026Filing
  • 8-K eventPatent Allowance NotificationMay 27, 2026Filing
  • 8-K eventRecord Sales AnnouncementMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 30, 2026Filing
  • 8-K eventClinical Case Study ReleasedApr 14, 2026Filing

Questions

Frequently asked questions

What is bioAffinity Technologies, Inc.'s market cap?

bioAffinity Technologies, Inc. (BIAF) has a market capitalization of $7.7M.

What is BIAF's P/E ratio?

A meaningful P/E ratio is not available for BIAF — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BIAF's price-to-book (P/B) ratio?

BIAF trades at 1.05 times book value per share.

Are insiders buying BIAF stock?

SEC Form 4 filings show no open-market insider buys at bioAffinity Technologies, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

TRIB

Trinity Biotech plc

$7.4M

NOTV

Inotiv, Inc.

$9.8M

BGLC

BioNexus Gene Lab Corp.

$4.4M

INBS

Intelligent Bio Solutions Inc.

$1.6M

ISPC

iSpecimen Inc.

$437K

VNRX

VolitionRx Limited

$15.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.